These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

51 related articles for article (PubMed ID: 3575404)

  • 1. [The stabilization of physostigmine preparations].
    Raether G; Pranz M; Wollmann H
    Pharmazie; 1987 Jan; 42(1):59-60. PubMed ID: 3575404
    [No Abstract]   [Full Text] [Related]  

  • 2. [Stabilization of physostigmine salicylate injection solutions].
    Trose D; Slowig P
    Pharmazie; 1985 Feb; 40(2):124-6. PubMed ID: 3923501
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The stabilization of physostigmine salicylate injection solutions. 2].
    Trose D; Kässmann A
    Pharmazie; 1990 Oct; 45(10):783-5. PubMed ID: 2089391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative determination of pillocarpine in crude drugs, pharmaceutical preparations and with physostigmine in combination.
    Mohamed YA; El-Sayed MA
    Pharmazie; 1975 Jan; 30(1):60-1. PubMed ID: 237291
    [No Abstract]   [Full Text] [Related]  

  • 5. [Colorimetric determination of physostigmine salicylate in eye drops].
    Riabtseva IM; Guseva LN; Kuleshova IM
    Farmatsiia; 1972; 21(3):75-7. PubMed ID: 5035655
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparative stability test of epinephrine, isoprenaline, physostigmine, promethazine and ascorbic acid solutions].
    Raether G; Jensch HP; Katzorke D; Wollmann H
    Pharmazie; 1988 Feb; 43(2):132-3. PubMed ID: 3393582
    [No Abstract]   [Full Text] [Related]  

  • 7. Colorimetric determination of physostigmine in pharmaceuticals.
    Khalil SK; Patterson BD
    J Pharm Sci; 1971 Sep; 60(9):1387-8. PubMed ID: 5567590
    [No Abstract]   [Full Text] [Related]  

  • 8. Determination of physostigmine and pyridostigmine in pharmaceutical formulations by capillary electrophoresis.
    Havel J; Patocka J; Bocaz G
    J Capill Electrophor Microchip Technol; 2002; 7(5-6):107-12. PubMed ID: 12546159
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of pH and sodium metabisulphite on the stability of physostigmine sulphate solutions to heat and ionizing radiation.
    Fletcher G; Davies DJ
    J Pharm Pharmacol; 1968 Dec; 20():Suppl:108S+. PubMed ID: 4388142
    [No Abstract]   [Full Text] [Related]  

  • 10. Proceedings of the 3rd Symposium on stabilization and evaluation methodology of pharmaceutical preparations, Nagoya Distinction and identification of drug binding sites on human serum albumin by kinetic method appling the esterase-like activity.
    J Pharmacobiodyn; 1980 Sep; 3(9):s1-11. PubMed ID: 7463304
    [No Abstract]   [Full Text] [Related]  

  • 11. [Determination of geneserine in pharmaceutical solutions].
    GLOESENER E
    J Pharm Belg; 1958; 13(3-4):117-20. PubMed ID: 13550058
    [No Abstract]   [Full Text] [Related]  

  • 12. The absolute configuration of physostigmine.
    Hill RK; Newkome GR
    Tetrahedron; 1969 Mar; 25(6):1249-60. PubMed ID: 5346203
    [No Abstract]   [Full Text] [Related]  

  • 13. Differential spectrophotometric estimation of some pharmaceutical compounds. I. Applying relative absorbance value.
    Abdine H; el-Sayed MA; Ibrahim SA
    Planta Med; 1973 Jun; 23(4):398-400. PubMed ID: 4732122
    [No Abstract]   [Full Text] [Related]  

  • 14. [Stability testing of drug substances and preparations, a contribution to drug safety].
    Kny L; Stark A
    Pharmazie; 1983 Oct; 38(10):666-70. PubMed ID: 6657735
    [No Abstract]   [Full Text] [Related]  

  • 15. [Photometric determination of physostigmine].
    REICHELT J
    Cesk Farm; 1953 Sep; 2(9):293-5. PubMed ID: 13116244
    [No Abstract]   [Full Text] [Related]  

  • 16. Assay of physostigmine in aged ophthalmic solutions.
    Berg BH
    Acta Pharm Suec; 1966 Jun; 3(3):209-18. PubMed ID: 5967306
    [No Abstract]   [Full Text] [Related]  

  • 17. [Detection of Maillard's reaction in pharmaceutical preparations].
    Pellerin F; Baylocq D; Mancheron D
    Ann Pharm Fr; 1971 Nov; 29(11):529-32. PubMed ID: 5138615
    [No Abstract]   [Full Text] [Related]  

  • 18. Pounds. 2. Apply"pounds. 2. Apply.
    Abdine H; el-Sayed MA; Ibrahim SA
    Pharmazie; 1974 Feb; 29(2):103-5. PubMed ID: 4838456
    [No Abstract]   [Full Text] [Related]  

  • 19. Factorial designs in pharmaceutical preformulation studies. II. Studies on drug stability and compatibility in the solid state.
    Ahlneck C; Waltersson JO
    Acta Pharm Suec; 1986; 23(3):139-50. PubMed ID: 3766159
    [No Abstract]   [Full Text] [Related]  

  • 20. Skin permeation of physostigmine from fatty acids-based formulations: evaluating the choice of solvent.
    Wang MY; Yang YY; Heng PW
    Int J Pharm; 2005 Feb; 290(1-2):25-36. PubMed ID: 15664127
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.